Rare disease registries for certain lysosomal storage disorders, including, but not limited to, Fabry, Gaucher, MPS I, and Pompe diseases (each, a Registry)

  • sponsor
Updated on 23 November 2020


Rare disease registries for certain lysosomal storage disorders, including, but not limited to, Fabry, Gaucher, MPS I, and Pompe diseases (each, a Registry)


The Rare Disease Registry Program (including but not limited to, Gaucher, Fabry, MPS I, and Pompe diseases) is a multi-center, international, longitudinal, observational program that tracks the natural history and outcomes of patients with these rare diseases.

Protocol Number: Rare Disease Registry


The Registry program is a multi-center, international, observational program for patients with these rare diseases that was designed to track the natural history and outcomes of patients. No experimental intervention is given; thus, a patient will undergo clinical assessments and receive standard of-care treatment as determined by the patient’s physician. As the Registries are a voluntary program, the total number of patients with these diseases who will participate in the Registries and the associated person-years of follow-up are not pre-defined, as not all patients have been identified, nor will all patients wish to participate. The Registry databases have been designed to collect a variety of baseline and follow-up data obtained through routine clinical and laboratory assessments. All data submission is voluntary and there are no pre-determined follow-up periods. Participating sites are encouraged to enter comprehensive baseline data at enrollment and to perform follow-up assessments at regular intervals. While the protocols provide Recommended Schedules of Assessments, each physician is solely responsible for determining the appropriate clinical care for each patient.

Condition Fabry Disease
Clinical Study IdentifierTX141086
Last Modified on23 November 2020


Yes No Not Sure

Inclusion Criteria

All patients with a confirmed diagnosis of their specific disease who are willing and able to provide written informed consent and any additional authorization documents required by local law to send health information to the Registry are eligible for inclusion

Exclusion Criteria

There are no exclusion criteria in this Registry. Patients are allowed to participate in clinical studies and may be receiving different therapies to treat their disease. However, data entry (with the exception of data collected prior to the patient’s participation in the clinical study) should be put on hold in the Registry during the patients’ participation in the clinical study. When the patient has discontinued or completed the clinical study, data entry can resume. Where the clinical study was sponsored by Genzyme, the Registry team may work with participating physicians, as necessary and appropriate, to facilitate the entry of data from the clinical study (to the extent such data are also collected by the Registry) into the Registry database
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note